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F-specific filamentous phage of Escherichia coli (Ff: f1, M13, or fd) are long thin
filaments (860 nm × 6 nm). They have been a major workhorse in display technologies
and bionanotechnology; however, some applications are limited by the high length-
to-diameter ratio of Ff. Furthermore, use of functionalized Ff outside of laboratory
containment is in part hampered by the fact that they are genetically modified viruses.
We have now developed a system for production and purification of very short
functionalized Ff-phage-derived nanorods, named Ff-nano, that are only 50 nm in
length. In contrast to standard Ff-derived vectors that replicate in E. coli and contain
antibiotic-resistance genes, Ff-nano are protein-DNA complexes that cannot replicate
on their own and do not contain any coding sequences. These nanorods show an
increased resistance to heating at 70◦C in 1% SDS in comparison to the full-length
Ff phage of the same coat composition. We demonstrate that functionalized Ff-nano
particles are suitable for application as detection particles in sensitive and quantitative
“dipstick” lateral flow diagnostic assay for human plasma fibronectin.
Keywords: phage display, filamentous phage, M13 phage, fd phage, f1 phage, lateral flow, nanorod, fibronectin-
binding protein
Introduction
Filamentous bacteriophages are ﬁlament-like bacterial viruses (Day, 2011; Rakonjac et al., 2011).
The F-pilus-speciﬁc ﬁlamentous phage of Escherichia coli, Ff (f1, M13, and fd), are resistant to heat,
wide range of pH and ionic detergents, to which the tailed phage, such as λ, are sensitive (Branston
et al., 2013). The Ff phage virions are 860 nm in length and 6 nm in diameter; they contain circular
single-stranded DNA of ∼6400 nt (Day et al., 1988; Marvin et al., 2014). The virion is composed
of ﬁve proteins. The major coat protein pVIII, that forms the shaft of the ﬁlament, is present in
the virion in a few thousand copies. Two pairs of minor coat proteins, pIII/pVI and pVII/pIX,
form two asymmetric ends of the ﬁlament. They are each present in the virion in up to ﬁve copies.
Infection with ﬁlamentous phage is mediated by binding of a minor protein, pIII, to the primary
and secondary receptors, the tip of the F-pilus and the TolQRA protein complex spanning the
periplasm and the inner membrane, respectively. The primary receptor, however, is not essential
for infection; in the presence of Ca2+ ions as many as 1% of E. coli cells in the culture can be
infected with Ff (Russel et al., 1988). TolQRA, a conserved protein complex in Gram-negative
bacteria, appears to be both an essential and universally required protein for ﬁlamentous phage
infection, allowing what appears to be a low-eﬃciency broad-spectrum infection of Gram-negative
bacteria by this group of phage (Heilpern and Waldor, 2000).
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After entry into the host cytoplasm, the circular ssDNA
genome [the positive (+) strand] of Ff replicates as an episome via
a rolling-circle mechanism, one strand at a time. Replication of
each strand requires speciﬁc sequences called negative (−) strand
origin and positive (+) strand origin [(−) and (+) ori] and host
proteins (Model and Russel, 1988; Rakonjac et al., 2011). In addi-
tion, replication from (+) origin requires phage-encoded protein
pII (Asano et al., 1999). In addition to origin of replication, a cis
sequence called packaging signal (PS) is required for targeting the
(+) strand ssDNA to assembly machinery and assembly of the
virions (Russel andModel, 1989). The (−) and (+) strand origins
of replication, as well as the packaging signal, are together often
referred to as the f1 origin of replication and are located within
a ∼400 nt long intergenic sequence (IG; Supplementary Figure
S1A). When inserted into plasmids, the IG (f1 ori) allows rolling
circle replication in the presence of a helper phage, followed
by packaging of the resulting ssDNA into Ff-derived particles;
such vectors are known as phagemids. Some phagemid vectors
are designed to express translational fusions with the Ff virion
proteins and are used in phage display technology (Vieira and
Messing, 1987; Barbas et al., 1991).
The virion proteins are all integrated into the inner mem-
brane prior to assembly. The Ff virions are assembled by trans-
fer of proteins from the inner membrane onto the ssDNA
genome through a mechanistically and structurally poorly under-
stood secretion-like process, mediated by phage-encoded trans-
envelope secretion-assembly machinery (Russel andModel, 2006;
Rakonjac et al., 2011). Whereas the diameter of the wild-type
Ff virion is constant, the length depends on the length of pack-
aged ssDNA. The shortest Ff-derived particles reported were
50 nm in length, containing circular ssDNA of 221 nt (Specthrie
et al., 1992). They were produced by helper-phage-assisted repli-
cation from a specially constructed origin of replication, 303 nt
in length (Supplementary Figure S1B), inserted into a plasmid.
This 303-nt sequence comprises two (+) origins of replication,
ori1 and ori2, ﬂanking a packaging signal. The ori1 corresponds
to the core (I) region of the (+) ori and serves as an initia-
tor of replication. The extended (II) region of the (+) ori was
not included in the ori1, in order to minimize the replicon size
and therefore the particle length. Replication in the absence of
region II of the (+) ori requires a helper phage containing gIIIRI
mutant (Dotto et al., 1984). The ori2 is further shortened; it
does not bind pIIIRI and cannot serve as an initiator; its role
is to terminate replication of the (+) strand. In the presence of
pIIIRI, a segment between the two pII cut sites (TTCTTT↓AATA)
in the two (+) origins is replicated and the resulting 221 nt
ssDNA is ligated to form a circular ssDNA molecule. A PS
inserted in between the two (+) origins allows assembly of
this short circular ssDNA into 50 nm-long Ff-like particles
(Specthrie et al., 1992).
The physical properties of Ff phage, coupled with their
amenability to genetic engineering using recombinant DNA tech-
nology, have enabled their extensive use in modern biotech-
nology and nanotechnology. Ff is central to phage display, a
combinatorial technology in which libraries of peptides, anti-
bodies, or proteins are displayed on the virion surface, whilst
the corresponding coding sequences are encapsulated inside the
virions. This physical link between the displayed protein and its
coding sequence allows aﬃnity screening and enrichment of rare
variants that bind to a ligand or a bait, from vast libraries of
variants (Smith, 1991; Rebar and Pabo, 1994; Zwick et al., 1998;
Bradbury and Marks, 2004). The Ff phage have more recently
been used as nanoparticle-templates to display arrays of organic
and inorganic molecules (Bernard and Francis, 2014) for appli-
cations ranging from tissue targeting (Souza et al., 2010) and
drug delivery (Bar et al., 2008) to nanoelectrodes (Lee et al.,
2009), light-harvesting (Dang et al., 2013) and diagnostic devices
(Petrenko, 2008). Furthermore, the liquid crystalline properties
of Ff have been exploited to assemble colloidal membranes and
other structures (Gibaud et al., 2012) and for applications in tis-
sue engineering (Chung et al., 2011) and colorimetric sensors (Oh
et al., 2014).
The current applications of Ff phage could be expanded by
manipulating the length of the particles, potentially resulting in
nanomaterials of novel properties. Short rods may be preferred
over the long ﬁlaments in some applications, such as diagnostic
methods that use diﬀusion (lateral ﬂow) of diagnostic particles
through complex matrices. Furthermore, short particles lacking
viral or antibiotic-resistance genes would lower regulatory hur-
dles and consumer concerns, allowing wider application outside
of laboratory containment.
To expand the versatility and decrease the risks Ff-derived
nanoparticle use, we have developed a system for high-
eﬃciency production of short functionalized Ff-derived particles
(50 nm × 6 nm) that we named “Ff-nano.” These particles do
not carry any genes and cannot replicate inside a bacterial cell
nor can they integrate into bacterial chromosome. We show that
these short particles are more resistant to heating in the pres-
ence of ionic detergent SDS compared to the full-length phage.
Furthermore we demonstrate that functionalized Ff-nano can
be used as detector particles for a high-sensitivity dipstick assay
detecting a test analyte, ﬁbronectin, at a concentration of 0.35
femtomoles/µL (2 × 108 molecules/µL).
Materials and Methods
Bacteria, Phage, and Growth Conditions
All E. coli strains used in this study are derivatives of labora-
tory strain K12. They are listed in Table 1. Strain K561 was
used for growth of the helper phage R408 [f1 PS gIX(T30A)
TABLE 1 | Bacterial strains.
Strainsa Genotype Reference
TG1 supE44 (hsdM-mcrB)5 (rk− mk−
McrB− ) thi (lac-proAB) F’ [traD36
lacIq (lacZ)M15 proA+B+ ]
Carter et al. (1985)
K561 HfrC λ+ relA1 spoT1 T2R (ompF627
fadL701) lacZ lac1q
The Rockefeller University
collection
K1030 HfrC λ− relA1 spoT1 T2R (ompF627
fadL701) supD zed508::Tn10
The Rockefeller University
collection
K2092 TG1 supD zed508::Tn10 This work
aAll strains are derivatives of Escherichia coli K12.
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gIIIRI(C143T) gtrxA2; Russel et al., 1986]. Strains containing a
supD mutation, K1030, and K2092 were used for growth of
gVIIIamber mutant phage R777 (R408, gVIIIam25) or Rnano3
(R777, MCS in gIII) or R408-3 (R408, MCS in gIII). K2092
was obtained by co-transducing the supD mutation with the
zed508::Tn10 (Tetr marker) from strain K1030 into strain TG1
(Carter et al., 1985) using generalized transduction with P1 (Cmr
Clr-100; Sternberg and Maurer, 1991). The zed508::Tn10 (Tetr)
transductants were tested for plaque formation by phage R777
(supD is co-transduced with zed508::Tn10 at a frequency of 80%).
Strain K1030 containing pIV-expressing plasmid pPMR132
(Linderoth et al., 1997) was used for growth of phage R676 (f1,
gIV, gVIIIam25; Feng et al., 1999).
The cultures were propagated in DifcoTM 2xYT (Yeast
Extract Tryptone) liquid medium [Becton-Dickinson (BD)
and Company, USA] at 37◦C with continuous shaking
(200 rpm), or on 2xYT agar plates (1.2% Bacto-Agar, BD)
at 37◦C unless otherwise stated. The medium was supple-
mented with suitable antibiotics where required, sourced
from Sigma–Aldrich and Goldbio (USA). Antibiotics were
used at the following concentrations: Ampicillin (Amp)
100 µg/mL, Kanamycin (Km) 30 µg/mL, Chloramphenicol
(Cm) 25 µg/mL, and Tetracycline (Tet) 15 µg/mL unless
otherwise indicated.
Construction of Phage and Plasmids
General molecular biology techniques for cloning, PCR ampli-
ﬁcations and sequencing were carried out as described in
(Sambrook and Russell, 2001). Molecular biology reagents were
sourced from New England Biolabs Inc. (USA), Roche Molecular
Biochemicals (Germany), Life Technologies Inc. (USA), and
Takara (Japan). Oligonucleotides used in cloning, sequencing and
PCR reactions were manufactured by Life Technologies Inc. and
Integrated DNA Technologies Inc. (USA). DNA sequencing was
carried out at the Massey University Genome Services, Institute
of Fundamental Sciences, Palmerston North, New Zealand.
The small and large scale plasmid and phage closed-circular
double-stranded (RF) DNA was prepared using High Pure
Plasmid Isolation Mini and Midiprep kits (Life Technologies;
Roche Molecular Biochemicals) according to the manufacturers’
instructions.
Construction of the recombinant phage and the plas-
mid pNJB7 is described in Supplementary Methods and
Supplementary Figure S2. Brieﬂy, helper phage R777 was con-
structed from phage R408 and R676 (Feng et al., 1999), by com-
bining the R408 origin of replication and gIIIRI with gVIIIam25 of
R676.
The helper/vector phage Rnano3 was constructed by com-
bining the gVIIIam25 mutation with a 45-nt multiple cloning
site (MCS) identical to that of the phage display vector
pHEN2 (Marks et al., 1991) in the R408 background. Another
helper/vector, containing the identical MCS, but wild-type gVIII,
named R408-3, was constructed in parallel.
Recombinant helper/vector Rnano3FnB was constructed by
inserting coding sequence of ﬁbronectin binding (FnB) domain
from Streptococcus pyogenes (Rakonjac et al., 1995) into the MCS
of Rnano3.
The Ff-nano-producing plasmid pNJB7 was constructed by
inserting the Ff-nano origin of replication ampliﬁed from plas-
mid pLS7 (Specthrie et al., 1992) into the high-copy-number
vector pCR4-TOPO (Life Technologies).
Phage Growth
All helper-vector phage stocks were prepared initially from a sin-
gle plaque using a plate method. Brieﬂy, phage were extracted
from a plaque into 1 mL of 2xYT by slow rotation at room
temperature for 1 h, ﬁltered through a 0.45 µm-pore ﬁlter to
remove the E. coli cells and titrated on an appropriate strain. To
make a plate stock, 105-107 phage from the dissolved plaque were
mixed with a culture of an appropriate host in 2xYT soft agar,
plated, and incubated overnight. The phage were extracted into
5 mL of 2xYT overlaid onto the surface of the lawn, followed by
slow shaking for 1 h at room temperature. The 2xYT contain-
ing extracted phage was collected and ﬁltered to remove E. coli.
Titers of the plate stocks were typically∼1011 per mL. These plate
stocks were then used for preparation of larger-volume stocks
using a standard single-round infection of exponentially growing
liquid cultures at a multiplicity of infection (m.o.i.) of 50 phage
per bacterium.
Purification of the Ff-nano Particles
An exponentially growing culture (2–8 L) of K1030 carrying
pNJB7 (Ff-nano-producing plasmid) was infected with appro-
priate helper phage (R777, Rnano3, or Rnano3FnB) at an m.o.i.
of 50 and incubated at 37◦C without shaking for 20 min, to
allow infection. Incubation was continued overnight at 37◦Cwith
shaking at 200 rpm. The subsequent day, cells were pelleted
(7000 × g for 20 min at 4◦C) and the supernatant contain-
ing the Ff-nano and full-length helper phage was subjected to
diﬀerential two-step polyethylene glycol (PEG) precipitation, to
separate the two types of particles from each other, as described
(Specthrie et al., 1992). Brieﬂy, in the ﬁrst precipitation, cul-
ture supernatant was subjected to 2.5% w/v PEG8000/0.5 M
NaCl and incubated overnight at 4◦C to precipitate the full-
length helper phage. Precipitated full-length helper phage were
collected by centrifugation at 16,500 × g for 45 min at 4◦C.
Supernatant containing the Ff-nano particles was transferred to
sterile containers, whereas the full-length phage pellet was sus-
pended in TBS (50 mM Tris, 150 mM NaCl, pH 7.0). In the
second precipitation, solid PEG8000 was added to the super-
natant, to a ﬁnal concentration of 15%, and incubated overnight
at 4◦C. The following day the Ff-nano-enriched precipitate was
collected by centrifugation (at 16,500 × g for 45 min at 4◦C)
and the pellet was resuspended in TBS. The full-length phage
and Ff-nano fractions (resuspended pellets from 2.5 and 15%
PEG, respectively) were further subjected to successive deter-
gent treatments and precipitations to decrease contamination
with fragments of inner and outer membranes [Sarkosyl (1%
w/v) and Triton X-100 (0.1% v/v)]. Full length helper phage
were recovered after each detergent treatment by precipita-
tion with 2.5% PEG and Ff-nano with 15% PEG as described
above, except that precipitations were carried out at room tem-
perature to decrease co-precipitation of detergents with the
particles.
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Ff-nano particles were further puriﬁed away from the remain-
ing full-length helper phage based on the large diﬀerence in size.
Native agarose gel electrophoresis was carried out as described
(Nelson et al., 1981; Rakonjac and Model, 1998). Preparative
native agarose gel electrophoresis was carried out on 0.8% agarose
gels. Upon completion of electrophoresis, the agarose gel slabs
containing the bands corresponding to full-length or Ff-nano
particles were separately cut out and transferred to dialysis tubes
(Novagen, D-tube dialyzer Maxi, MWCO 12–14 kDa) contain-
ing 500 µL of sterile 1 × TAE buﬀer (40 mM Tris-acetate
buﬀer, pH 8.3, 1 mM EDTA). These tubes were then placed
into an electrophoresis chamber in sterile 1 × TAE buﬀer and
electrophoresed overnight at 0.5 V/cm at 4◦C. After removing
the gel slices from tubes, the phage particles (full-length or Ff-
nano) were precipitated overnight at 4◦C using 2.5 or 15% PEG,
respectively, in 0.5 M NaCl. The precipitate was dissolved in an
appropriate amount of 1 × PBS (137 mM NaCl, 2.7 mm KCl,
10 mM Na2HPO4, 1.8 mM KH2PO4, and stored at −80◦C until
further use.
Quantification of Ff-derived Particles
Phage R777, Rnano3, and Rnano3FnB (containing gVIIIam25
mutation) were titrated on E. coli supD strains K1030 or K2092
to determine the number of plaque-forming units per milliliter,
using standard phage plating, and titration methods. To quan-
tify non-infectious Ff-nano, the particles were disassembled in
SDS-containing buﬀer (1% SDS, 1 × TAE, 5% glycerol, 0.25%
bromophenol blue) at 100◦C for 5 min and subjected to elec-
trophoresis in 1.2% agarose gel in 1 × TAE buﬀer. After elec-
trophoresis, the ssDNA released from disassembled Ff-derived
particles was stained with ethidium bromide (Supplementary
Figure S3) and quantiﬁed by densitometry (Rakonjac and Model,
1998). The amount of ssDNA in any band is not linearly pro-
portional to the intensity of ﬂuorescence, therefore each gel
contained a set of twofold dilutions of puriﬁed full length f1
ssDNA that were used for calibration (Supplementary Figure
S3). Gels were photographed by a CCD camera (Biorad, USA).
Image Gage V4.0 and Microsoft Excel were used for densitom-
etry and calculations, respectively. A second-order polynomial
function was used to ﬁt the standard curve. Amounts of ssDNA
were converted to the genome equivalents based on the molec-
ular weight of the ssDNA genome. The molecular weight of the
Ff-nano ssDNA genome was in turn calculated from its length
(221 nt) and nucleotide composition (derived from the DNA
sequence).
Native agarose gel electrophoresis was used to separate the
intact full-length (helper) phage from Ff-nano particles, for
analysis and puriﬁcation. The bands containing intact parti-
cles were detected in agarose gels after the in situ stripping
the virion proteins oﬀ the ssDNA by soaking the gel in 0.2 M
NaOH for 1 h, followed by neutralization with 0.45 M Tris
pH 7.0 and staining with ethidium bromide (Supplementary
Figure S4).
Microscopy
The phage samples for non-cryo TEM analysis were adsorbed
onto glow-discharged carbon-coated grids, negatively stained
with a 1% uranyl acetate solution, and examined on a Phillips
CM-10 microscope at the Manawatu Microscopy and Imaging
Centre (MMIC, Institute of Fundamental Sciences, Massey
University).
Cryo-negative staining was performed at the University of
Pittsburgh, Pittsburgh, PA, USA, on an FEI (Hillsboro, OR)
Tecnai F20 microscope equipped with a Gatan (Pleasanton,
CA, USA) 626 cryoholder and operated at 200 kV and nom-
inal magniﬁcation of 50,000×. Brieﬂy, 3 µL of sample were
pipetted onto a holey carbon/copper grid that had been brieﬂy
glow-discharged. The grid was then placed sample-down onto
a 100 µL droplet of 16% ammonium molybdate (in the pH
range 7.0–8.0) and ﬂoated for 60 s, following the cryo-negative
staining procedure (Adrian et al., 1998). The grid was then
removed, blotted and plunge-frozen into liquid ethane using an
FEI Vitrobot Mk III. Images were collected using standard low-
dose techniques on a Gatan Ultrascan 4000 CCD camera with
post-column magniﬁcation of 1.33×, yielding a pixel size at the
sample of 2.3 Å.
Phage ELISA Assay
Phage Enzyme Linked Immunosorbent Assay (ELISA Harlow
and Lane, 1999) was carried out in the 96-well plates (Nunc-
Immuno MaxySorpTM, Denmark). The wells were coated
overnight at 4◦C with 100 µL of human plasma ﬁbronectin
(Sigma–Aldrich, USA) at 20 µg/mL in 100 mM sodium bicar-
bonate buﬀer, pH 9.5. All subsequent steps were carried out at
room temperature. The wells were washed once with 300 µL
of PBS containing 0.05% Tween 20 (PBST) and blocked with
250 µL of 2% (w/v) Bovine Serum Albumin (BSA) in PBS for
2 h. After washing wells three times with 300 µL of PBST,
Rnano3FnB full-length phage or Ff-nano particles (1 × 108)
in 100 µL of PBS were added to the wells. Negative controls
(buﬀer and protein) were PBS and 2% BSA in PBS, respec-
tively, whereas negative phage controls were the full-length
phage and the Ff-nano particles derived from “empty” vec-
tor/helper Rnano3 (and therefore not displaying FnB). The
plates were then incubated for 2 h. The unbound parti-
cles were removed by extensive washing with PBST (300 µL,
seven times). To detect phage particles bound to ﬁbronectin
in the wells, 100 µL of rabbit anti-pVIII (polyclonal anti-
body to M13, fd, and f1, Progen Biotechnik; Germany) was
added at the concentration of 0.1 µg/mL in 1× PBS and
incubated for 1 h. The wells were then washed ﬁve times
with 300 µL PBST buﬀer. Next, 100 µL of secondary HRP-
conjugated anti rabbit antibody was added to all wells at a
dilution of 1:2000 and then washed with 300 µL PBST seven
times. The HRP bound to the plate was detected with 1-
StepTM Turbo TMB-ELISA reagent (Thermo Scientiﬁc). The
enzyme reaction was stopped by adding 25 µL of 0.5 M
H2SO4. The signal was quantiﬁed by measuring absorbance
at 450 nm.
Labeling of Ff-derived Particles Using
Fluorescein Isothiocyanate
Fresh Fluorescein IsoThioCyanate (FITC) solution (1 mg/mL)
was prepared in 1 M NaCO3/NaHCO3 (pH 9.0) buﬀer. Ff-nano
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(0.5 × 1013 in 500 µL) was precipitated using 15% PEG/0.5 M
NaCl and the same amount of the full-length phage with 2.5%
PEG/0.5 M NaCl. The precipitate was dissolved in 200 µL of 1 M
NaCO3/NaHCO3 (pH 9.0) buﬀer. The FITC solution (50µL) was
added to the suspension of precipitated Ff-nano or full-length
phage and the reaction mixture was rotated in the dark for 1 h
at room temperature. The reaction was stopped by adding 10 µL
of the NH4Cl and the particles were puriﬁed by a series of two
PEG8000 precipitations using the concentrations appropriate for
Ff-nano (15%) and full-length phage (2.5%). The pellet obtained
after the second PEG8000 precipitation was suspended in 100 µL
of 1× PBS and stored at 4◦C in the dark until further use.
Dipstick Assays
Hi-Flow Plus membrane cards were used to make the dip-
sticks (Millipore Corporation). These cards contain nitrocellu-
lose membranes cast on a 2 mil (0.001 inch; USA) polyester
ﬁlm backing. The reagents for the test and control lines were
applied to the membrane using a mechanical dispenser. Collagen
I (Sigma; 1 µg/µL in 0.25% acetic acid;) was dispensed at the
test line, whereas undiluted mouse anti-pVIII antibody or anti-
FITC antibody (0.5 to 1 µg/µL) was dispensed at the control
line. The protein-loaded cards were allowed to dry at 37◦C for
1 h and were subsequently cut into 0.5 cm × 2.5 cm size dip-
sticks using an automatic card-cutting tool (BIODOT membrane
cutter; SM5000; sheet slitter). The dipsticks were stored in zip-
lock sealed bags at room temperature in a dark place until use.
The membrane has a ﬂow rate of 46 s/2.5 cm (total length of the
dipstick).
The distal end of protein-loaded dipstick was dipped into the
50 µL mixture of analyte (ﬁbronectin, 5 µg/50 µL for initial
detection and serial twofold dilutions starting from 0.5 µg/50 µL
for quantitative detection) and the detection particles that was
pre-incubated for 30min. Full-length phagewere used at 1× 1010
per assay, and Ff-nano (or Ff-nanoFnB) particles at 1 × 1011 per
assay. Dipsticks were allowed to stand in solution for 30 min
and dried for 1 h at 37◦C. The FITC-labeled particles on the
dipsticks were detected using a phosphoimager (Fuji, Japan).
Unlabeled particles were visualized by immune-blotting using
rabbit pVIII-speciﬁc antibody (0.66 µg/mL; Progen Biotech) for
1 h at room temperature, followed by ﬁve washes of 5 min each
with PBST. Rabbit IgG-speciﬁc antibody conjugated to alkaline
phosphatase (Sigma, USA) was used as the secondary antibody.
The dipsticks were washed again ﬁve times with PBST, and
developed using Nitro Blue Tetrazolium (NBT) and 5-Bromo-
4-Chloro-3-Indolyl Phosphatase (BCIP) in alkaline buﬀer (Blake
et al., 1984). Densitometric analysis of the signal at the control
and test lines in quantitative assays was performed using ImageJ
software (Schneider et al., 2012).
Results
The Ff-nano Production and Purification
System
In this work we have constructed an Ff-derived phage
display system for production of functionalized nanorods
(50 nm × 6 nm) we named Ff-nano (Figure 1). In the ﬁrst
stage, we modiﬁed a setup for production of short phage origi-
nally published by Specthrie et al. (1992) to increase the amount
(per cell) of the 221-nt circular ssDNA available as a template for
assembly of the short particles. This was achieved by inserting
the 303-nt short-phage (microphage or Ff-nano) origin of repli-
cation (Supplementary Figure S1) into the high-copy-number
plasmid pCR4-TOPO (in contrast to the low-copy-number plas-
mid pBR322 used in the original system), to obtain plasmid
pNJB7. Furthermore, a new helper phage, named Rnano3, was
constructed. The helper phage Rnano3, in contrast to the original
helper phage R474 used for short phage production (Specthrie
et al., 1992), is not only a helper but also a phage display vector.
Rnano3 was designed for display of proteins as fusions with phage
protein pIII that is present in up to ﬁve copies at one end of the
Ff-derived particles. Infection of cells containing plasmid pNJB7
with the helper phage/vector Rnano3 resulted in production of
the 50 nm × 6 nm particles (Ff-nano or microphage; Figure 2)
and full-length phage.
The 50-nm-particle production was originally reported to
be improved in the presence of helper phage that produces
decreased amount of the major coat protein pVIII. Decreased
amount of pVIII presumably favors initiation and termination
of assembly over elongation of particles, thereby decreasing the
co-packaging of short 221 nt ssDNA with the helper phage
DNA into the full-length particles and increasing production
of short particles (Specthrie et al., 1992). In contrast to R474
helper used previously for the short phage production, which
has a mutation lowering transcription of not only gVIII but
also in gIX (Russel and Model, 1989; Specthrie et al., 1992),
the Rnano3 helper phage/vector that we constructed produces
decreased amount of pVIII without aﬀecting gIX expression.
This speciﬁc eﬀect on pVIII is achieved by using a suppressed
gVIIIam25 mutation, which contains a TAG stop codon in the
gVIII sequence at codon 25 (replacing the GAG codon for Glu).
When the Rnano3 phage infects a supD strain, the TAG codon
is translated into Glu or Ser (Rogers and Soll, 1988). The eﬃ-
ciency of the gVIIIam25 mutant translation in the supD strains
(K1030 and K2092) is <50% that of the wild-type, resulting
in a lower number of pVIII copies produced per cell than in
an infection with phage containing a wild-type gVIII. Besides
the helper/vector with decreased amount of pVIII, we also con-
structed and examined helper/vector R408-3 that is identical to
Rnano3 apart from having a wild-type gVIII. Rnano3 and R408-3
were both found to support production of the Ff-nano parti-
cles (Supplementary Figure S5). As predicted, co-packaging of
the 221-nt ssDNA derived from the Ff-nano origin of replica-
tion with the full-length phage genome appeared to be increased
in the R408-3 full-length phage fraction after diﬀerential PEG
precipitation, relative to that of Rnano3 (gVIIIam25 mutant),
however, the production of Ff-nano particles was also increased
(Supplementary Figure S5).
Ff-nano particles were partially puriﬁed away from the
full-length helper phage by diﬀerential PEG precipitation (see
Materials and Methods). The full-length helper phage was ﬁrst
precipitated out of the culture supernatant in 2.5% PEG8000,
0.5 M NaCl, followed by increase in PEG8000 to 15% to
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FIGURE 1 | The system for production of functionalized Ff-nano.
Escherichia coli cells containing the Ff-nano production plasmid pNJB7 were
infected with the helper phage Rnano3FnB containing the coding sequence of a
“probe” or “detector” protein fused to pIII. Upon infection, pII from the helper
phage induces positive strand replication from the pNJB7 Ff-nano origin of
replication and also provides all other phage proteins and assembly machinery
for production of the Ff-nano particles. All five copies of pIII are fusions to the
probe (only three copies of pIII fusions are shown).
FIGURE 2 | Transmission electron micrographs (TEM) of Ff-nano
particles. (A) Cryo-negative TEM of particles obtained using the R777 helper
phage. (B) Negative-stain TEM of particles obtained using the Rnano3
helper/vector. Arrow in (A) points to a double-length particle. Samples were
prepared as described in Section “Materials and Methods.”
precipitate Ff-nano (Specthrie et al., 1992). However, this method
resulted in 0.7% full-length phage still remaining in the Ff-nano
fraction (Table 2). We used native agarose gel electrophoresis to
separate the short particles from the full-length phage follow-
ing the diﬀerential PEG precipitation (Supplementary Figure S4).
Preparative agarose gel electrophoresis is simple, fast, eﬀective,
and less expensive than the size fractionation by Sepharose CL2B
columns used by Specthrie et al. (1992). The band containing
Ff-nano was excised and the particles were extracted by electroe-
lution (seeMaterials andMethods for details of puriﬁcation). The
native preparative agarose gel electrophoresis puriﬁcation step
decreased the full-length helper phage frequency in the ﬁnal puri-
ﬁed sample by a factor of 1400, down to 5.0 × 10−6 relative to
Ff-nano (Table 2). This method was also relatively eﬃcient in
recovery of the Ff-nano (31% of the input; Table 2).
Physical Properties of the Ff-nano
Morphology
Puriﬁed Ff-nano were negatively stained and visualized by
cryo-electron and transmission electron microscopy (Figure 2).
Dimensions of the Ff-nano are 50 nm by 6 nm, matching those
reported in Specthrie et al. (1992). The Ff-nano particle termini
appear asymmetric, one pointy, and one blunt, as reported for
the Ff phage (Gray et al., 1979). In the cryo-negative micro-
graphs Ff-nano formed sheets composed of individual Ff-nano
aligned in alternating orientations. In addition, in a larger ﬁeld,
about 3.5% (6 out of 172) double-length Ff-nano particles could
be observed (Supplementary Figure S6). This is consistent with
observations of full-length ﬁlamentous phage, which, depend-
ing on the genotype, contain some proportion of particles that
are longer than the majority by a factor of two or multiple
lengths of the virion, and containing two or more sequentially
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TABLE 2 | Purification of the Ff-nano by native agarose gel electrophoresis and electroelution.
Ff-nano
(total numberc)
Recovery of the
Ff-nanod
Helper phage
(total numbere)
Helper: Ff-nano
ratiof
Fold decrease of
helper: Ff nano ratiog
Inputa 6.4 × 1014 N/A (input) 4.5 × 1012 7.0 × 10−3 N/A (input)
Electro-purified Ff-nanob 2.0 × 1014 31% 9.9 × 108 5.0 × 10−6 1400
aStarting material loaded onto the preparative gel corresponds to the Ff-nano-enriched lysate obtained by differential PEG precipitation.
bFf-nano-band was excised from the agarose gel, extracted by electroelution, purified and concentrated (see Materials and Methods).
cDetermined by densitometry (see Materials and Methods).
dRatio of the Ff-nano number in the electro-purified sample to the amount in the input.
eDetermined by titration.
fDetermined by dividing the total number of full-length helper phage with the total number of the Ff-nano particles.
gFold decrease of the helper to Ff-nano ratio (“helper: Ff-nano ratio”) was calculated by dividing the “helper: Ff-nano ratio” in the input with the “helper: Ff-nano ratio” in
the electro-purified sample (data column four; row one divided by the row two value).
packaged genomes (Rakonjac and Model, 1998). We note that
the Ff-nano particles visualized in the electron micrographs do
not have any signs of the extra balls of density that are sometimes
observed attached to the pIII end of the ﬁlament and correspond
to free-moving N1N2 domains of pIII (Gray et al., 1979).
Stability to Heating in the Presence of Sodium
Dodecyl Sulfate
In the course of Ff-nano analyses, we observed that the stan-
dard protocol for Ff phage in vitro disassembly, heating in a
buﬀer containing 1% (34 mM) ionic detergent sodium dodecyl
sulfate (SDS) for 5 min at 70◦C, was not eﬃcient in releas-
ing ssDNA from the Ff-nano particles (data not shown). This
indicated that the Ff-nano particles could be more stable to
heat/SDS treatment than the full length helper phage, even
though both are assembled within the same E. coli cell. To
test this hypothesis, a time-course experiment of heat exposure
was used to monitor disassembly of full-length helper phage
and Ff-nano isolated from the same culture using diﬀerential
PEG precipitation and preparative agarose electrophoresis, as
described in the previous section. Approximately 2 × 1012 Ff-
nano or 1 × 1011 full-length phage were heated at 70◦C in
the presence of 1% SDS for a period from 5 to 20 min; one
sample was also incubated at 100◦C for 5 min. Disassembly
of the helper (full-length) phage and Ff-nano particles was
monitored by agarose gel electrophoresis (Figure 3). Released
ssDNA was directly visualized by staining with ethidium bro-
mide (Figure 3B), while the ssDNA that remained encapsidated
inside the intact Ff-derived particles (resistant to heat/SDS treat-
ment) was not detectable by direct staining. In order to visualize
the SDS-resistant intact particle bands after electrophoresis, the
coat proteins were dissociated from ssDNA in situ by soak-
ing the gel in an alkaline buﬀer (0.4 M NaOH), followed by
neutralization and re-staining of the gel by ethidium bromide
(Figure 3A).
When the full-length (helper) phage virions were analyzed,
the untreated samples (without SDS or heating) did not con-
tain any free ssDNA. All full-length phage were therefore intact
(all ssDNA was contained within the virion; Figure 3; com-
pare the corresponding untreated sample lanes in gels A and
B). In the presence of 1% SDS, at the ﬁrst time-point (5 min)
of incubation at 70◦C, however, all ssDNA was in the free form
and none in the intact phage particles, hence the vast majority
FIGURE 3 | Ff-nano resistance to heating in SDS. (A) Intact (undamaged)
particles and free ssDNA released from particles by the heat/SDS-treatment.
Free ssDNA was visualized by staining the gel with ethidium bromide. Bands
corresponding to the intact particles were visualized after soaking the gel in
0.4 M NaOH (see Materials and Methods for details). Gel sections containing
the bands corresponding to the free ssDNA and intact full-length and Ff-nano
particles are boxed. (B) Free ssDNA only, released by the heat/SDS treatment
(visualized by direct ethidium bromide staining of the gel prior to NaOH
treatment).
of the full-length phage particles were sensitive to these condi-
tions (Figure 3A). In contrast, when the Ff-nano particles were
subjected to the same treatment (1% SDS at 70◦C), a large pro-
portion of the intact Ff-nano particles were detected, with some
free ssDNA observed at all time-points (Figure 3, compare the
70◦C-treated sample lanes in A vs. B). The amount of intact Ff-
nano particles decreased gradually at 70◦C between the 5 and
20 min time points, but nearly half stayed intact throughout the
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incubation. The intact Ff-nano were completely eliminated only
after incubation at 100◦C, conﬁrming that only at this higher
temperature is SDS able to disassemble all Ff-nano particles in the
sample (Figure 3, compare lane 12 in A vs. B). This experiment
demonstrates that the Ff-nano particles have superior resistance
to heating in the presence of ionic detergent SDS in comparison
to the full-length phage, requiring higher temperature (100 vs.
70◦C) for dissociation of most particles.
Functionalization of the Ff-nano
To test the potential of the Ff-nano-production system to assem-
ble functionalized particles that can be used for display of foreign
proteins, a fusion to pIII was constructed in the helper/vector
Rnano3. The displayed peptide was the FnB domain from serum
opacity factor (Sof), a surface protein of S. pyogenes (Rakonjac
et al., 1995). The Sof FnB domain is composed of three repeats of
a bacterial FnBmotif (PF02986) that each binds to the N-terminal
domain of Fibronectin (Fn) with a low nanomolar dissociation
constant (Rakonjac et al., 1995; Schwarz-Linek et al., 2006). The
high aﬃnity of FnB for the Fn makes it a good candidate as a
detector molecule and FnB-Fn combination is a good detector-
analyte pair to investigate the use of Ff-nano as a display particle
and for its applicability to lateral ﬂow dipstick diagnostic devices.
The functionalized helper/vector encoding the FnB-gIII fusion
was named Rnano3FnB. When E. coli containing the Ff-nano-
origin plasmid (pNJB7) was infected with Rnano3FnB, the Ff-
nano particles displaying FnB (named Ff-nanoFnB) were pro-
duced together with the full-length helper phage (Figure 1). The
helper (full-length) Rnano3FnB phage and the Ff-nanoFnB par-
ticles obtained using this helper were separated by diﬀerential
PEG precipitation and each of the long and the short phage
were further puriﬁed using native agarose gel electrophoresis fol-
lowed by electroelution, as described in the previous section.
Phage ELISA was performed to conﬁrm that the FnB domain was
displayed (schematically represented in Figure 4A). Rnano3FnB
full-length and Ff-nanoFnB particles exhibited binding to immo-
bilized ﬁbronectin as indicated by strong ELISA signal detected
for ﬁbronectin-coated wells incubated with these phage parti-
cles (OD450 = 1.2 with 108 particles per well in the presence of
40 ng/µL of Fn). No signal over background levels (OD450 = 0.1;
intrinsic to the phage ELISA) was detected in control wells incu-
bated with Ff-nano particles that did not display FnB, derived
from the infection with vector Rnano3 (without the FnB domain)
nor in the wells coated with BSA only (from which ﬁbronectin
was omitted; Figure 4B), apart from the full-length Rnano3 par-
ticles (not displaying FnB) which gave a low signal OD450 = 0.3 in
the presence of Fn. In conclusion, Ff-nanoFnB particles detected
Fn and were hence displaying FnB. All Ff-nano and Ff-nanoFnB
samples used in the assays were imaged by TEM to conﬁrm the
purity and morphology of the particles (data not shown).
Development of a Lateral Flow Assay for
Fibronectin Using Ff-nano
Dipstick Assays Using Ff-nano
To investigate the detection of ﬁbronectin (the analyte) in solu-
tion using the Ff-nano displaying FnB domains as the detec-
tor (probe) in lateral ﬂow devices, a simple dipstick assay was
FIGURE 4 | Confirmation of Ff-nano-FnB display by phage ELISA
assay. (A) Schematic representation of the fibronectin-binding phage ELISA
assay. (B) Assay result. Fibronectin was immobilized on a microtiter plate at a
saturating concentration of 40 ng/µL (2 µg per well of a 96-well plate),
whereas control wells for each assay were coated with PBS alone or BSA
(1%) in PBS. The wells were exposed to (1 × 108) Ff-nanoFnB or full-length
phage Rnano3FnB that both displayed FnB as a pIII fusion, or control particles
Ff-nano and Rnano3 that did not display FnB. After washing of the wells,
bound Ff-nano or full-length phage were detected using a primary antibody to
the major coat protein, then the secondary HRP-conjugated antibody,
followed by detection of HRP through an enzymatic reaction according to the
standard ELISA protocols. Data are presented as an average of three
measurements. Error bars show standard deviation.
designed and tested (see Figure 5A for a schematic representa-
tion of the Fn-detection dipstick assay). The dipsticks used in this
assay contained human type I collagen at the test line. Collagen
binds ﬁbronectin with high aﬃnity (Engvall et al., 1981).
The assays were carried out using particles that were either
unlabeled (Figure 5B), or FITC-conjugated (Figure 5C). The
unlabeled particles were captured on the control line usingmouse
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FIGURE 5 | Fibronectin dipstick assay using Ff-nanoFnB. (A) Schematic
representation of a lateral-flow dipstick assay; Fn-detection dipstick assay
using: (B) unlabeled; (C) FITC-labeled particles. Each assay (50 µL) contained
1 × 1010 full-length Rnano3 (Rnano3FnB) or 1 × 1011 Ff-nano (or
Ff-nanoFnB) particles and 1 µg of Fn. The assay was performed and the
unlabeled or FITC-labeled particles were detected as described in Section
“Materials and Methods.” The test line, printed with collagen solution, appears
as a triple band when the signal is high. This is due to secondary lines flanking
the main line that form during printing of collagen on the card. The triple
banding during printing is caused by the acidity of the solution, necessary to
keep the collagen soluble (0.25% acetic acid).
pVIII-speciﬁc antibodies and detected on the dipstick, after the
assay was completed, using rabbit pVIII-speciﬁc antibody. The
FITC-labeled phage were captured on the control line using
FITC-speciﬁc antibodies and detected on the dipstick using a
phosphoimager.
As expected, the Ff-nanoFnB particles and full-length phage
displaying FnB (Rnano3FnB) showed binding to collagen at the
test line in the presence of ﬁbronectin [Figure 5B (sticks 3 and
7); Figure 5C (sticks 1 and 5)]. The Ff-nanoFnB particles gave
no background in the absence of Fn (analyte), whereas the full-
length FnB-displaying phage showed some unspeciﬁc binding to
the collagen test line (Figure 5B, dipstick 8 and Figure 5C, dip-
stick 6) in the absence of Fn. The Ff-nano and full-length particles
that did not display FnB did not bind to the test line, indicating
the lack of unspeciﬁc binding of phage to collagen [Figure 5B
(sticks 1, 2, 5, and 6); Figure 5C (sticks 3, 4)].
Quantification of Fibronectin Using Dipstick Assay
To estimate the lower limit of detection using the Ff-nano dip-
stick assay and the range within which the signal depended
on the amount of analyte, serial twofold dilutions of analyte
(ﬁbronectin) were assayed using this format. Since the dip-
stick assay signal was stronger in the unlabeled particle assay
(Figure 5B) in comparison to the assay with FITC-labeled par-
ticles (Figure 5C), the former were used in this experiment.
The lowest concentration of ﬁbronectin at which a signal
could be detected at the test line was 0.08 ng/µL, equiva-
lent to 0.35 femtomoles/µL or 2 × 108 molecules/µL, hence
this is the sensitivity limit of the Ff-nanoFnB-based ﬁbronectin
detection dipstick assay (Figure 6A). The number of Ff-nano
particles used in this assay was 2 × 1011, the highest num-
ber that did not show unspeciﬁc binding to nitrocellulose (data
not shown).
Densitometric analysis of the signal showed that the ratio
between the test and control lines was proportional to the log
of Fn (analyte) concentration (Figures 6B,C) over a range of
concentrations between 0.625 and 10 ng/µL, consistent with
simple visual comparison of control band density. These are
much lower concentrations of Fn than those measured in the
serum of healthy individuals (259–400 ng/µL; Allard et al.,
1986). A suitable serum dilution would therefore adjust the
concentration to the quantitative detection range of the assay.
Furthermore, variations of Fn concentration in disease fall
within one order of magnitude relative to those of healthy indi-
viduals (Choate and Mosher, 1983; Cembrowski and Mosher,
1984; Weller et al., 1988; Honest et al., 2002; Mosher, 2006;
Eissa et al., 2010).
Discussion
Ff-nano Production and Purification
Ff-derived functionalized nanoparticles reported to date are
based on the long and thin ﬁlamentous template, whose hydro-
dynamic properties are not favorable for diﬀusion-based appli-
cations. From ethical and regulatory perspectives, the use of
Ff-phage outside of the laboratory containment, in particular in
home-use diagnostic devices or as carriers for tissue targeting of
drugs, antigens, or diagnostic markers, is potentially controver-
sial because they are recombinant viruses. Due to the propensity
of Ff to infect Gram-negative bacteria via the ubiquitous TolQRA
complex in the absence of their primary receptor, the F-pilus
of E. coli (Russel et al., 1988; Heilpern and Waldor, 2000), they
could potentially infect a wide range of Gram-negative bacteria.
This includes a possibility of mobilization and horizontal gene
transfer of antibiotic-resistance-encoding genes, present in most
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FIGURE 6 | Detection range of Fibronectin using Ff-nanoFnB. Series of
Fn (analyte) dilutions analyzed using Ff-nanoFnB-based dipsticks were used
for determination of lower detection limit (A) and quantitative range (B,C).
Asterisk in (A) denotes the lowest Fn concentration at which the signal was
detected on the test line. The graph in (C) corresponds to the Test/Control
signal ratio vs. Fn concentration. Each assay contained Ff-nanoFnB particles
(2 × 1011) mixed with Fn at the indicated final concentrations in a total volume
of 50 µL. The assay was performed and the signal quantified as described in
the Section “Materials and Methods.”
of the phage display vectors, among the gut or environmental
bacteria. The Ff-derived particles (virions) containing phage dis-
play vectors have been shown to be taken up by mammalian
cells in culture (Burg et al., 2002), hence there is a possibil-
ity that the encapsidated DNA permanently inserts into patient
genomes.
To convert functionalized ﬁlamentous phage particles into
non-replicating protein-DNA complexes, we have assembled
functionalized short Ff-derived particles that contain 221-nt
single-stranded DNA devoid of protein-coding sequences. Like
Ff phage (f1, M13, and fd), genomes, the 221-nt ssDNA of the
Ff-nano cannot integrate into E. coli chromosome as it lacks the
necessary cis elements, such as genes for tRNA and/or sequences
recognized by speciﬁc recombinases, that are used by some inte-
grative ﬁlamentous phage to insert into bacterial chromosomes
using the host recombinases (Rakonjac et al., 2011). Furthermore,
given that it does not contain a negative (−) origin of replica-
tion, Ff-nano ssDNA cannot commence replication even if the
specialized helper phage (containing IRI mutation in gII) coin-
fects the same cell. Therefore, Ff-nano improves the prospect
of Ff ﬁlamentous phage applications outside of the laboratory.
Given that these particles cannot replicate in any organism with-
out extensive human intervention, they are considered not to
be organsims in most legislatures regulating biological products,
including the very strict New Zealand Hazardous Substances and
New Organisms Act.
Furthermore, the length-to-diameter ratio of these particles is
15–20-fold smaller than that of the Ff particles derived from stan-
dard phagemid and phage vectors, improving the diﬀusion rate of
the particles.
We have developed a production and puriﬁcation pipeline
for 50 nm particles by converting an Ff phage short-particle
production system (Specthrie et al., 1992) into a high-
eﬃciency system for producing functionalizable nanoparti-
cles that we named Ff-nano. The increase in eﬃciency was
achieved by using a high-copy-number plasmid containing
the Ff-nano origin of replication and construction of helper
phage Rnano3 and R408-3 that are also phage display vec-
tors, containing cloning sites for construction of protein fusions
to pIII.
In the Ff-nano puriﬁcation, we introduced size-separation
from the full-length helper phage by preparative agarose elec-
trophoresis and electroelution. This strategy achieved excellent
resolution, leading to a high enrichment of the Ff-nano parti-
cles over the full-length helper phage at a low cost and high
recovery of the Ff-nano particles (31%). Overall, this production
and puriﬁcation system yields around 1014–1015 Ff-nano parti-
cles from 2 to 8 L of E. coli culture. The Ff-nano samples obtained,
however, still contain full-length phage at an approximate fre-
quency of 1 in 200,000 (5 × 10−6). Although the helper phage
that we use do not contain antibiotic resistance genes, they still
represent an undesired population that needs to be eliminated
in order to obtain fully virus-free Ff-nano samples. Helper plas-
mids are expected to overcome this residual phage contamination
in the Ff-nano preparations, as they do not contain a Ff origin
of replication (Chasteen et al., 2006). A helper plasmid derived
from helper phage VCSM13 (containing Kmr marker and p15A
plasmid origin of replication, but not the gIIIRI mutation) was
constructed by deletion of the IG and tested for the Ff-nano pro-
duction, however, it did not support the Ff-nano production to a
detectable level, despite being eﬃcient in supporting replication
of standard phagemids that contain complete f1 origin of replica-
tion (Sattar, 2013). We have subsequently constructed a helper
plasmid derived from Rnano3, which in preliminary analyses
supported Ff-nano production (Jasna Rakonjac, unpublished).
This helper plasmids is the next step toward the phage-free
production of Ff-nano particles.
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Ff-nano Particle Stability
The Ff-nano were more resistant to heating in 1% (34 mM) ionic
detergent SDS in comparison to the full-length phage. This prop-
erty is solely due to the diﬀerence in phage length, as the assayed
populations of full-length and Ff-nano particles were puriﬁed
from the same E. coli culture and therefore had identical protein
composition. Ff ﬁlamentous phage dissociation in the presence
of SDS was investigated in detail by Stopar et al. (1998, 2002,
2003) using Electron Spin Resonance (ESR), circular dichroism
and NMR. Solubilization of the major coat protein with deter-
gent occurs when SDS displaces a pVIII subunit in the virion,
replacing pVIII–pVIII interactions by pVIII-detergent interac-
tions (Stopar et al., 1998). When a critical ratio of detergent
to phage is reached, even a single pVIII subunit displacement
across the ﬁlament triggers a cooperative dissociation of the
virion (Ikehara et al., 1975; Stopar et al., 2002). In our experiment,
the full-length virions were rapidly and completely disassem-
bled after incubation in 1% SDS at 70◦C for 5 min, which is the
time point when over half of the Ff-nano particles in the sam-
ple remain intact (Figure 3). This length-dependent diﬀerence
can be reconciled by the Ff-nano presenting a 17-fold smaller
surface area for detergent interaction in comparison to the full-
length phage, thereby decreasing the odds of steric imbalance
caused by SDS–pVIII interactions per virion and resulting in
much larger numbers of resistant particles under the same condi-
tions. In addition, due to the short length of Ff-nano, the potential
imperfections of pVIII packing that could occur in each parti-
cle due to mechanical bending and twisting of the ﬁlament are
greatly reduced. Bending can be observed in the electron micro-
scopic images of full-length phage (Gray et al., 1979; Rakonjac
and Model, 1998), but not Ff-nano (Figure 2A; Supplementary
Figure S5). The short length, preventing the bending of the ﬁl-
ament may therefore confer additional stability to Ff-nano in
comparison to full-length virions.
From the technological standpoint, the increased stability of
Ff-nano particles may be beneﬁcial in applications that involve
high temperature in detergent-containing environment, or other
harsh conditions. Given the higher resistance of Ff-nano to heat-
ing in 1% SDS at 70◦C in comparison to complete sensitivity of
the full-length phage, it is possible to develop conditions that
will completely degrade the full-length phage in the puriﬁed
Ff-nano preparation, while completely preserving the Ff-nano
particles, thereby eliminating the full-length phage from the Ff-
nano preparations. This approach will be possible for applications
where the residue of SDS in the sample is not an issue, and
where the Ff-nano particles display peptides that are resistant to
denaturation by SDS.
Ff-nano Functionalization and Use as a
Detection Particle
To allow exploration of Ff-nano in biotechnological applications,
we have converted the Ff-nano production system into a dis-
play system through insertion of MCS into gIII of the helper
phage/vector, between the signal sequence and the mature por-
tion of the protein. This system was then used to develop a
dipstick ﬁbronectin detection assay using Ff-nano displaying the
ﬁbronectin-binding domain from S. pyogenes (Ff-nanoFnB). No
unspeciﬁc binding to the analyte was detected using the Ff-
nanoFnB detection particles, in contrast to residual non-speciﬁc
signal observed using the full-length phage Rnano3FnB. The
quantitative range of assay using Ff-nanoFnB detection particles
was found to be between 0.625 and 10 ng/µL, with the logarith-
mic dependence between the Fn concentration of Fn and the ratio
of the signal intensity between the test and control lines. This
range appropriate for measuring the Fn concentration in human
serum after a suitable dilution. Variations of Fn concentration
can be used as indicators of several diseases, such as bladder
cancer, liver damage, deﬁbrination syndrome, arterial thrombo-
sis, preterm birth, or ocular damage (Choate and Mosher, 1983;
Cembrowski and Mosher, 1984; Weller et al., 1988; Honest et al.,
2002;Mosher, 2006; Eissa et al., 2010). These variations fall within
one order of magnitude, corresponding to the quantitative range
of the Ff-nanoFnB-based dipstick assay. The Ff-nanoFnB can
therefore be the basis for development of quantitative ﬁbronectin
assay.
In conclusion, this work describes a novel display system
that functionalizes short Ff phage-derived nanorods. It further
demonstrates one application for use in dipstick assays. Given
a large range of publications describing applications where Ff
virions are used, including the templates for assembly of inor-
ganic structures, diagnostics, tissue templating, imaging, and
drug targeting (Bar et al., 2008; Petrenko, 2008; Lee et al.,
2009; Souza et al., 2010; Chung et al., 2011; Dang et al., 2013;
Bernard and Francis, 2014; Oh et al., 2014), Ff-nano as short
non-viral functionalized particles will likely ﬁnd many diverse
applications.
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